This highly anticipated talk on Chimeric Antigen Receptor T-Cell Therapies, a recent innovation in cancer immunotherapy involving genetic modification of T-Cells, will be hosted on Tuesday 26 Feb. We have managed to secure a well-established speaker from UCL, Dr. Paul Maciocia, a clinical lecturer and researcher trainee fellow in haematology, who is involved in CAR T-Cell research.
This will be our biggest talk of the year, you are certain to learn a lot about the future of cancer treatment and research by attending. Don't miss out! We will also be giving out draw prizes for student attendees plus free stash from RCR! Follow us on Facebook and Instagram to stay updated.
We look forward to seeing you there! :)
Barts Oncology Society Team